JamesDavidBrandtMD

PubMed

• 210 citations
  Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study
  Steven L. Mansberger, Mae O. Gordon, Henry D. Jampel, Anjali M. Bhorade, James D. Brandt
  Ophthalmology. 2012-09-01
• 1906 citations
  The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.
  Mae O. Gordon, Julia A. Beiser, James D. Brandt, Dale K. Heuer, Eve J. Higginbotham
  Archives of Ophthalmology. 2002-06-01
• 234 citations
  Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
  Steven J. Gedde, Joyce C. Schiffman, William J. Feuer, Leon W. Herndon, James D. Brandt
  American Journal of Ophthalmology. 2007-01-01

Journal Articles

• Visual field quality control in the Ocular Hypertension Treatment Study (OHTS).  
  Keltner JL, Johnson CA,Cello KE, Bandermann SE, Fan J, Levine RA, Kass MA, Gordon MO and the Ocular Hypertension Treatment Study Group, Journal of Glaucoma 16(8):665-669
• The Ocular Hypertension Treatment Study: Topical Ocular Hypotensive Medication Delays or Prevents Primary Open Angle Glaucoma in African American Individuals.  
  Higginbotham EJ, Gordon MO, Beiser JA, Drake MV, Bennett GR, Wilson MR, Kass MA for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 122:813-820
• Baseline risk factors for the development of POAG in the Ocular Hypertension Treatment Study.  
  Coleman AL, Gordon MO, Beiser JA, Kass MA for the Ocular Hypertension Treatment Study Group, American Journal of Ophthalmology 138(4):684-685
• Incorporating the results of the Ocular Hypertension Treatment Study into clinical practice. Letter to Editor.  
  Kass MA, Gordon MO, Kymes SM for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 123:1021-1022
• Normal visual field test results following glaucomatous visual field endpoints in the Ocular Hypertension Treatment Study.  
  Keltner JL, Johnson CA, Levine RA, Fan JJ, Cello KE, Kass MA, Gordon MO for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 123:1201-1206
• Test-retest reproducibility of optic disk deterioration detected from stereophotographs by masked graders.  
  Parrish RK, Schiffman JC, Feuer WJ, Anderson DR, Budenz DL, Wells-Albornoz M-C, Vandenbrouke R, Kass MA, Gordon MO for the Ocular Hypertension Study Group, American Journal of Ophthalmology 140:762-764
• Asymmetries and visual field summaries as predictors of glaucoma in the Ocular Hypertension Treatment Study (OHTS).  
  Levine RA, Demirel S, Fan JJ, Keltner JL, Johnson CA, Kass MA for the Ocular Hypertension Study Group, Investigative Ophthalmology & Visual Science 47:3896-3903
• The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study.  
  Keltner JL, Johnson CA, Anderson DR Levine RA, Fan JJ, Cello KE, Quigley HA, Budenz DL, Parrish RK, II, Kass MA, Gordon MO for the Ocular Hypertension Treatment Stud..., Ophthalmology 113(9):1603-1612
• Topical Ocular Hypotensive Medication and Lens Opacification: Evidence From the Ocular Hypertension Treatment Study.  
  Herman DC, Gordon MO, Beiser JA, Chylack LT, Lamping KA, Schein OD, Soltau JB, Kass MA and the Ocular Hypertension Treatment Study Group, American Journal of Ophthalmology 142:800– 800
• Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study.  
  Budenz DL, Anderson DR, Feuer WJ, Beiser JA, Schiffman J, Parrish RK, II, Piltz-Seymour JR, Gordon MO, Kass MA for the Ocular Hypertension Treatment Study Group, Ophthalmology 113(12):2137-2143
• A validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.  
  The Ocular Hypertension Treatment Study Group and the European Glaucoma Prevention Study (EGPS) Group, Ophthalmology 114(1):10-19
• Comparison of initial intraocular pressure response to topical ß-adrenergic antagonists and prostaglandin analogues in African-Americans and white individuals in the ...  
  Mansberger SL, Hughes BA, Gordon MO, Spaner SD, Beiser JA, Cioffi GA, Kass MA and the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 125(4):454-459
• Classification of visual field abnormalities in the Ocular Hypertension Treatment Study.  
  Johnson CA, Keltner JL, Cello KE, Edwards M, Bandermann SE, Kass MA, Gordon MO for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 121:643-650
• Diabetes and Glaucoma.  
  Kass MA, Gordon MO for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 126(5):746-a-7
• Is a History of Diabetes Mellitus Protective Against developing Primary Open-Angle Glaucoma?  
  Gordon MO, Beiser JA, Kass MA for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 126:280-1
• Variability of Intraocular Pressure Measruements in Observation Participants in the Ocular Hypertension Treatment Study.  
  Bhorade AM, Wilson BS, Gordon MO, Weinreb RN, Kass MA and the Ocular Hypertension Treatment Study Group, Ophthalmology 116:717-724
• Delaying Treatment of Ocular Hypertension – The Ocular Hypertension Treatment Study.  
  Kass MA, Gordon MO, Gao F, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP, Parrish RK, Wilson MR for the Ocular Hypertension Treatment Study Group, Archives of Ophthalmology 128(3):276-287
• The Incidence of Retinal Vein Occlusion in the Ocular Hypertension Treatment Study.  
  Barnett EM, Fantin, A, Wilson BS, Kass MA, Gordon MO for the Ocular Hypertension Treatment Study Group, Ophthalmology 117:484-488
• The Utility of the Monocular Trial: Data from the Ocular Hypertension Treatment Study.  
  Bhorade AM, Wilson BS, Gordon MO, Palmberg P, Weinreb RN, Miller E, Chang RT, Kass MA for the Ocular Hypertension Treatment Study Group, Ophthalmology 117:2047-2054
• Six-month Comparison of Bimatoprost Once-Daily and Twice-Daily with Timolol Twice-Daily in Patients with Elevated Intraocular Pressure.  
  Sherwood, Mark J. & James D. Brandt for the Hypotensive Lipid Study Groups 1 and 2, Survey of Ophthalmology 45(Suppl 4):S361-S368
• One-Year, Randomized Study Comparing Bimatoprost and Timolol in Glaucoma and Ocular Hypertension.  
  Higginbotham EJ, Schuman JS, Goldberg I, Gross RL, Vandenburgh AM, Chen K, Whitcup SM for the Bimatoprost Study Groups 1 and 2, Archives of Ophthalmology 120(10):1286-1293
• The Ahmed Baerveldt Comparison Study – Methodology, Baseline Patient Characteristics, and Intraoperative Complications.  
  Barton K, Gedde SJ, Budenz DL, Feuer WJ, Schiffman J for the Ahmed Baerveldt Comparison Study Group, Ophthalmology 118(3):435-442
• Treatment Outcomes in the he Ahmed Baerveldt Comparison Study after 1 Year of Follow-up.  
  Budenz DL, Barton K, Feuer WJ, Schiffman J, Costa VP, Godfrey DG, Buys YM for the Ahmed Baerveldt Comparison Study Group, Ophthalmology 118(3):443-452
• A 12-Month, Multicenter, Randomized, Double-Masked, Parallel-Group Comparison of Timolol-LA Once Daily and Timolol Maleate Ophthalmic Solution Twice Daily in the Tre...  
  Mundorf TK; Ogawa T; Naka H; Novak GD and Crockett RS for the US Istalol Study Group, Clinical Therapeutics 26(4):541-551
• Droplet-based interfacial capacitive sensing.  
  Nie B, Xing S, Brandt JD & Pan T, Lab on a chip
• Join now to see all

Books/Book Chapters

• Cornea. 
  Chapter: Glaucoma after Penetrating Keratoplasty 
  Brandt JD, Lim MC & O’Day DGEditors: Mannis & Kratchmer.Elsevier, LondonEdition 2,
• Medical Treatment of Glaucoma. 
  Chapter: Medical Management of Glaucoma in Infants and Children 
  Page 267 - 271Brandt JDEditors: Weinreb RN, Araie M, Susanna R, Goldberg I, Migdal C & Liebmann J.Kugler Publications, Amsterdam
• Pearls of Glaucoma Consultation. 
  Chapter: Incorporating Central Corneal Thickness into Clinical Practice 
  Brandt JDEditors: Caprioli, Coleman, Law & Giaconi.Springer, Germany
• Ophthalmology. 
  Chapter: Congenital Glaucoma 
  Brandt JDEditors: Yanoff & Duker.Mosby International, LondonEdition 3,
• Duane’s Clinical Ophthalmology. 
  Chapter: Surgery for Congenital Glaucoma 
  Brandt JD & Suhr, AWJ. B. Lippincott, Philadelphia
• Curbside Consultation in Glaucoma – 49 Clinical Questions. 
  Chapter: Should I measure central corneal thickness in all glaucoma patients? All Glaucoma Suspects 
  Brandt JDEditors: Heuer, Gedde & Lewis.Slack, Thorofare
• Glaucoma. 
  Chapter: The Impact of Central Corneal Thickness and Corneal Biomechanics on Tonometry 
  Brandt JD, Roberts CR, Sherwood MB & Sheets CWEditors: Shaarawy, Sherwood, Hitchings & Crowston.Elsevier, London
• Answers in Glaucoma. 
  Chapter: What is the practical importance of pachymetry in the clinical evaluation of glaucoma 
  Brandt JDEditors: Susanna & Weinreb.Cultura Médica, Rio de Janeiro
• Ophthalmology. 
  Chapter: What have we learned from the major glaucoma clinical trials 
  Brandt JD & Wilson MREditors: Grehn & Stamper.Springer, Germany
• Optics for Ophthalmologists – A Board-Review Manual 
  Sadun, AA & Brandt JDSpringer-Verlag, New York
• Ophthalmology. 
  Chapter: Congenital Glaucoma 
  Page 1475 - 1481Brandt JDEditors: Yanoff & Duker.Mosby International, LondonEdition 2,
• Ophthalmology. 
  Chapter: Trabeculotomy and Goniotomy 
  Page 1569 - 1576Brandt JDEditors: Yanoff & Duker.Mosby International, LondonEdition 2,
• Duane’s Clinical Ophthalmology. 
  Chapter: Surgery for Congenital Glaucoma 
  Brandt JDJ. B. Lippincott, Philadelphia
• Ophthalmology. 
  Chapter: Congenital Glaucoma 
  Brandt JDEditors: Yanoff & Duker.Mosby International, London
• Ophthalmology. 
  Chapter: Trabeculotomy and Goniotomy 
  Brandt JDEditors: Yanoff & Duker.Mosby International, London
• Duane’s Clinical Ophthalmology. 
  Chapter: Surgery for Congenital Glaucoma 
  Brandt JDJ. B. Lippincott, PhiladelphiaEdition 6,
• Consensus Series 4. 
  Chapter: Intraocular Pressure 
  Weinreb RN, Brandt JDEditors: Garway-Heath D & Medeiros F.Kugler Publications, The Netherlands
• Join now to see all

Lectures

• 35th Annual UC Davis Health System Eye Center Ophthalmology Symposium - Big Topics on the Big Island: An Update of Comprehensive Ophthalmology 2012 
  UC Davis Health System, Waikoloa, Hawaii - 6/13/2012
• 35th Annual Ophthalmology Symposium: Big Topics on the Big Island; An Update of Comprehensive Ophthalmology 
  UC Davis Health System, Waikoloa, Hawaii - 6/13/2012
• American Glaucoma Society 22nd Annual Meeting 
  American Glaucoma Society (AGS), New York, New York - 3/1/2012
• Tonometry. 
  Singapore
• Should Every Patient in a Glaucoma Practice undergo Pachymetry. 
  Subspecialty Day Anaheim, CA
• The Tube versus Trabeculectomy Study. 
  Massachusetts Eye & Ear Infirmary Harvard Medical School Boston, MA
• Re-Inventing Tonometry for the 21 st Century. 
  Massachusetts Eye & Ear Infirmary Harvard Medical School Boston, MA, 2006
• Why combination medicines? 
  Athens, Greece
• Assessing Glaucoma Risk – New tools for the Clinician [Keynote]. 
  Athens, Greece
• Understanding Corneal Thickness in the Management of Glaucoma. 
  World Congress of Ophthalmology São Paulo, Brazil, 2005
• IOP should not be adjusted for corneal thickness – Point/Counterpoint 
  American Academy of Ophthalmology Subspecialty Day Chicago, Illinois
• Individualizing Treatment based on the Major Glaucoma Trials. 
  Asia-Oceanic Glaucoma Symposium / Autralia-New Zealand Glaucoma Club Cairns, Queensland, Australia
• Central Corneal Thickness in Glaucoma Diagnosis & Management. 
  5 th International Glaucoma Symposium Cape Town, South Africa
• Glaucoma Drainage Implants – A re-appraisal of their role. 
  Royal Australia & New Zealand College of Ophthalmologists Tasmania Branch Meeting Hobart, Australi
• Glaucoma in Infants & Children. 
  Royal Australia & New Zealand College of Ophthalmologists Tasmania Branch Meeting Hobart, Australia
• The Ocular Hypertension Treatment Study. 
  Royal Australia & New Zealand College of Ophthalmologists Queensland Branch Journal Club Brisbane, A
• The Role of Corneal Thickness in Glaucoma Management. 
  4 th International Glaucoma Symposium Barcelona, Spain
• Decision-making after trabeculectomy has failed. 
  Singapore
• Global Risk Assessment in the Glaucoma Patient. 
  Durham, NC
• Ophthalmology’s Botanical Heritage. 
  Durham, NC
• What did we learn from OHTS? 
  Glaucoma Symposium Budapest, Hungary
• The OHTS-EGPS Risk Model. 
  Glaucoma Symposium Budapest, Hungary
• The role of CCT in interpreting IOP level. 
  University of Illinois Glaucoma Symposium Grand Cayman, BWI, 2007
• Tonometry and CCT. 
  19 th Annual Meeting of the Japanese Glaucoma Society Osaka, Japan
• The OHTS-EGPS Risk Model. 
  University of Illinois Glaucoma Symposium Grand Cayman, BWI
• Join now to see all

Other

• LEO Clinical Update on Glaucoma. 
  Mark B. Sherwood, James D. Brandt, Neil T
  San Francisco
• LEO Clinical Update on Glaucoma. 
  Mark B. Sherwood, James D. Brandt, Neil T
  San Francisco
• Measuring Outflow Resistance of an Eye. 
  Pan, Tingrui & Brandt, James D
• A method for enhancing outflow of aqueous humor in treatment of glaucoma. 
  Brandt, James D., Martha E. O’Donnell & Fitz-Roy E. Curry
• A method for enhancing outflow of aqueous humor in treatment of glaucoma. 
  Brandt, James D., Martha E. O’Donnell & Fitz-Roy E. Curry
• A method for enhancing outflow of aqueous humor in treatment of glaucoma. 
  Brandt, James D., Martha E. O’Donnell & Fitz-Roy E. Curry
• A method for enhancing outflow of aqueous humor in treatment of glaucoma. 
  Brandt, James D., Martha E. O’Donnell & Fitz-Roy E. Curry
• Join now to see all